| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $462.1M | +9.9% |
| Cost of Revenue | $201.8M | +0.2% |
| Gross Profit | $260.2M | +18.7% |
| R&D Expense | $6.6M | -11.8% |
| SG&A Expense | $117.0M | +26.2% |
| Operating Income | $143.3M | +13.2% |
| Pre-tax Income | $134.9M | +22.5% |
| Income Tax | $885K | +3787.5% |
| Net Income | -$5.9M | -153.8% |
| EPS (Basic) | -$0.69 | -155.6% |
| EPS (Diluted) | -$0.69 | -155.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161.4M | — |
| Short-term Investments | $44.1M | — |
| Accounts Receivable | $44.2M | -6.8% |
| Inventory | $44.2M | -1.4% |
| Current Assets | $297.7M | — |
| Total Assets | $333.4M | — |
| Current Liabilities | $77.5M | +9422.9% |
| Long-term Debt | $169.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $196.1M | +28.9% |
| Capital Expenditures | $6.9M | -7.5% |
| Investing Cash Flow | -$51.4M | -416.7% |
| Financing Cash Flow | -$54.9M | +49.5% |
| Free Cash Flow | $189.2M | +30.8% |
| -7.9% |
| Total Liabilities | $255.6M | — |
| Stockholders' Equity | $6.5M | +926.3% |